2019
DOI: 10.1016/j.cellimm.2019.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Inflammasome gene expression is associated with immunopathology in human localized cutaneous leishmaniasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 49 publications
0
9
0
2
Order By: Relevance
“…Abrogation of inflammasome priming in vivo likely has important consequences for parasite survival and anti-microbial immunity, given the role of NLRP3 activation and IL-1b secretion in restricting parasite load and lesion development (Lima-Junior et al, 2013). This may underlie the non-inflammatory, anergic diffuse form of leishmaniasis caused by L. am (Christensen et al, 2019;Scorza et al, 2017) in contrast to nonhealing lesions that were associated with inflammasome activation (Charmoy et al, 2016;Gupta et al, 2019;Lee et al, 2018;Moreira et al, 2017). Although the parasite effector mechanisms causing host cell immune suppression remain elusive and may involve various parasite-or host-derived signals, including anti-inflammatory cytokines such as IL-10 (Conaway et al, 2017), our study draws a detailed and complex picture of their impact on the host cell phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…Abrogation of inflammasome priming in vivo likely has important consequences for parasite survival and anti-microbial immunity, given the role of NLRP3 activation and IL-1b secretion in restricting parasite load and lesion development (Lima-Junior et al, 2013). This may underlie the non-inflammatory, anergic diffuse form of leishmaniasis caused by L. am (Christensen et al, 2019;Scorza et al, 2017) in contrast to nonhealing lesions that were associated with inflammasome activation (Charmoy et al, 2016;Gupta et al, 2019;Lee et al, 2018;Moreira et al, 2017). Although the parasite effector mechanisms causing host cell immune suppression remain elusive and may involve various parasite-or host-derived signals, including anti-inflammatory cytokines such as IL-10 (Conaway et al, 2017), our study draws a detailed and complex picture of their impact on the host cell phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…In a murine model of leishmaniasis, Aim2 has been shown to suppress pathogen control and promote tissue inflammation. 54 Toxoplasma gondii has also been reported to activate the AIM2 inflammasome, interestingly the outcome of which is an atypical caspase-8-dependent apoptosis rather than caspase-1-dependent pyroptosis. 27…”
Section: Anti-fungal and Anti-protozoan Host Defensementioning
confidence: 99%
“…A study by Gupta et al 52 showed that skin biopsies from L braziliensis ‐infected human localized cutaneous leishmaniasis (LCL) patients have increased mRNA transcript levels of NLRP3, IL‐1β, and other inflammasome‐associated markers including caspase‐1, AIM2, and NLRP1. Importantly, immunohistochemistry staining for NLRP3 and IL‐1β shows increased levels of these proteins in LCL biopsies compared to normal control skin biopsies 52 . In addition, several studies in mice have shown that Leishmania spp.…”
Section: Activation Of the Nlrp3 Inflammasome During Leishmania Spp mentioning
confidence: 99%
“…infection, the proposed mechanisms vary greatly. In support of a pathogenic role for inflammasome, NLRP1 and AIM2 inflammasomes have also been implicated to promote lesion development during L braziliensis infection 52,106 ; although the downstream mechanisms remain unexplored. Miltefosine, an FDA approved drug used for treating leishmaniasis, 107 inhibits LPS + ATP‐induced NLRP3 inflammasome activation and IL‐1β release—suggesting NLRP3 targeting may provide specific drug alternatives to the currently available drugs 108 .…”
Section: Perspectives and Conclusionmentioning
confidence: 99%